Top Markets
Coin of the day
Circio Holding ASA Circio Holding ASA

Circio Holding ASA

CRNA
Clasificación en acciones #18604
Circio Holding ASA, a biotechnology firm based in Oslo, Norway, and founded in... Circio Holding ASA, a biotechnology firm based in Oslo, Norway, and founded in 2010, specializes in the development of advanced circular RNA and immunotherapy treatments. Among its key innovations is TG01, a cancer vaccine aimed at specific driver mutations, which is currently progressing through three clinical trials for indications including multiple myeloma, pancreatic cancer, and lung cancer. The company also pioneers the circVec circRNA vector platform, an adaptable genetic module designed to facilitate the creation of diverse functional circular RNAs within human cells. This circVec platform is further supported by a collaborative agreement with Certest Biotec, S.L., focusing on its formulation. Formerly known as Targovax ASA, the company officially rebranded to Circio Holding ASA in May 2023.
Precio por acción
$0.88044964
Última sincronización: 2026-07-31
Capitalización bursátil
$192.54M
Cambio (1 día)
-0.71%
Cambio (1 año)
1,362.12%
País
NO
Comercio Circio Holding ASA (CRNA)

Categoría

Ratio P/B de Circio Holding ASA (CRNA)
Ratio P/B al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de Circio Holding ASA, el ratio P/B actual (TTM) es 0. Al final de 2026, el ratio P/B era 0.
Historial del ratio P/B de Circio Holding ASA desde 2026 hasta 2026
Ratio P/B al final de cada año
Año Ratio P/B Cambiar
Not enough data for the provided dates.
Ratio P/B de empresas similares o competidoras
Empresa Ratio P/B Diferencia del ratio P/B País
6.3419 -
US
6.2413 -
NL
3.7087 -
US
2.5054 -
AU
- -
CH